Potential anti-inflammatory effects of proton pump inhibitors: A review and discussion of the clinical implications

Digestive Diseases and Sciences

Volumn 54, Issue 11, 2009, Pages 2312-2317

  Kedika, Ramalinga R ^a,b   Souza, Rhonda F ^a,b   Spechler, Stuart Jon ^c  

^a VA North Texas Health Care System   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Anti inflammatory agents; Anti oxidants; Eosinophilic esophagitis; Inflammation; Oxidative stress; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BACTERIAL PERITONITIS; COMMUNITY ACQUIRED PNEUMONIA; DRUG MECHANISM; DRUG POTENCY; ENDOTHELIUM CELL; EPITHELIUM CELL; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HOSPITAL INFECTION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INTESTINE FLORA; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION; STOMACH MUCOSA INJURY; STOMACH ULCER; TREATMENT RESPONSE;

ANTIOXIDANTS; CYTOKINES; ENDOTHELIAL CELLS; GASTRIC MUCOSA; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; PEPTIC ULCER; PROTON PUMP INHIBITORS;

EID: 70350212812     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0951-9     Document Type: Review

References (49)

1. JM Shin G Sachs 2008 Pharmacology of proton pump inhibitors Curr Gastroenterol Rep 10 528 534 10.1007/s11894-008-0098-4 19006606
2. I Forgacs A Loganayagam 2008 Overprescribing proton pump inhibitors BMJ 336 2 3 10.1136/bmj.39406.449456.BE 18174564
3. A Lassen J Hallas OB Schaffalitzky De Muckadell 2004 Use of anti-secretory medication: a population-based cohort study Aliment Pharmacol Ther 20 577 583 10.1111/j.1365-2036.2004.02120.x 15339329 (Pubitemid 39243903)
4. H Ichikawa N Yoshida T Takagi N Tomatsuri K Katada Y Isozaki K Uchiyama Y Naito T Okanoue T Yoshikawa 2004 Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats World J Gastroenterol 10 2814 2817 15334676
5. M Kuroda N Yoshida H Ichikawa T Takagi T Okuda Y Naito T Okanoue T Yoshikawa 2006 Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis Int J Mol Med 17 89 93 16328016
6. U Heinzow T Schlegelberger 1994 Omeprazole in ulcerative colitis Lancet 343 477 10.1016/S0140-6736(94)92718-9 7905967
7. MR Namazi F Jowkar 2008 A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors J Clin Pharm Ther 33 215 217 10.1111/j.1365-2710.2008.00907.x 18452407 (Pubitemid 351629751)
8. SJ Weiss 1986 Oxygen, ischemia and inflammation Acta Physiol Scand Suppl 548 9 37 3019082
9. D Lapenna S de Gioia G Ciofani D Festi F Cuccurullo 1996 Antioxidant properties of omeprazole FEBS Lett 382 189 192 10.1016/0014-5793(96)00155-X 8612750 (Pubitemid 26092253)
10. XQ Li TB Andersson M Ahlström L Weidolf 2004 Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities Drug Metab Dispos 32 821 827 10.1124/dmd.32.8.821 15258107 (Pubitemid 38955611)
11. C Cederberg AB Thomson V Mahachai JA Westin P Kirdeikis D Fisher L Zuk B Marriage 1992 Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients Gastroenterology 103 913 918 1499942
12. C Blandizzi M Fornai R Colucci G Natale V Lubrano C Vassalle L Antonioli G Lazzeri M Del Tacca 2005 Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage World J Gastroenterol 11 4052 4060 15996031
13. WA Simon E Sturm HJ Hartmann U Weser 2006 Hydroxyl radical scavenging reactivity of proton pump inhibitors Biochem Pharmacol 71 1337 1341 10.1016/j.bcp.2006.01.009 16494850
14. K Biswas U Bandyopadhyay I Chattopadhyay A Varadaraj E Ali RK Banerjee 2003 A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical J Biol Chem 278 10993 11001 10.1074/jbc.M210328200 12529378 (Pubitemid 36792647)
15. O Pastoris M Verri F Boschi O Kastsiuchenka B Balestra F Pace M Tonini G Natale 2008 Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin Naunyn Schmiedebergs Arch Pharmacol 378 421 429 10.1007/s00210-008-0314-7 18545984
16. C Blandizzi G Natale G Gherardi G Lazzeri MC Marveggio R Colucci D Carignani M Del Tacca 1999 Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury Dig Dis Sci 44 2039 2050 10.1023/A:1026626519534 10548356 (Pubitemid 29510815)
17. TR Koch A Petro M Darrabie EC Opara 2004 Effect of the H, K-ATPase inhibitor, esomeprazole magnesium, on gut total antioxidant capacity in mice J Nutr Biochem 15 522 526 10.1016/j.jnutbio.2004.03.003 15350983 (Pubitemid 39209394)
18. JC Becker N Grosser C Waltke S Schulz K Erdmann W Domschke H Schroder T Pohle 2006 Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells Biochem Biophys Res Commun 345 1014 1021 10.1016/j.bbrc.2006.04.170 16712795 (Pubitemid 43776514)
19. M Ritter P Schratzberger H Rossmann E Wöll K Seiler U Seidler N Reinisch CM Kähler H Zwierzina HJ Lang F Lang M Paulmichl CJ Wiedermann 1998 Effect of inhibitors of Na+/H+-exchange and gastric H+/K+ ATPase on cell volume, intracellular pH and migration of human polymorphonuclear leucocytes Br J Pharmacol 124 627 638 10.1038/sj.bjp.0701864 9690853 (Pubitemid 28276798)
20. C Lafourcade K Sobo S Kieffer-Jaquinod J Garin FG van der Goot 2008 Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization PLoS ONE 3 7 e2758 10.1371/journal.pone.0002758 18648502
21. M Harada S Shakado S Sakisaka S Tamaki M Ohishi K Sasatomi H Koga M Sata K Tanikawa 1997 Bafilomycin A1, a specific inhibitor of V-type H+-ATPases, inhibits the acidification of endocytic structures and inhibits horseradish peroxidase uptake in isolated rat sinusoidal endothelial cells Liver 17 244 250 9387916
22. F Luciani M Spada A De Milito A Molinari L Rivoltini A Montinaro M Marra L Lugini M Logozzi F Lozupone C Federici E Iessi G Parmiani G Arancia F Belardelli S Fais 2004 Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs J Natl Cancer Inst 96 1702 1713 15547183
23. JH Wandall 1992 Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245 Gut 33 617 621 10.1136/gut.33.5.617 1319381
24. O Handa N Yoshida N Fujita Y Tanaka M Ueda T Takagi S Kokura Y Naito T Okanoue T Yoshikawa 2006 Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors Inflamm Res 55 476 480 10.1007/s00011-006- 6056-4 17122965 (Pubitemid 44826737)
25. M Suzuki M Nakamura M Mori S Miura M Tsuchiya H Ishil 1995 Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori J Clin Gastroenterol 20 Suppl 2 S93 S96 7594353
26. B Styrt MS Klempner 1986 Inhibition of neutrophil oxidative metabolism by lysosomotropic weak bases Blood 67 334 342 3002523
27. M Suzuki M Mori S Miura M Suematsu D Fukumara H Kimura H Ishil 1996 Omeprazole attenuates oxygen-derived free radical production from human neutrophils Free Radic Biol Med 21 727 731 10.1016/0891-5849(96)00180-3 8891677 (Pubitemid 26331104)
28. G Agastya BC West JM Callahan 2000 Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro Immunopharmacol Immunotoxicol 22 357 372 10.3109/08923970009016425 10952036
29. K Zedtwitz-Liebenstein C Wenisch S Patruta B Parschalk F Daxböck W Graninger 2002 Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity Crit Care Med 30 1118 1122 10.1097/00003246-200205000-00026 12006811
30. N Yoshida T Yoshikawa Y Tanaka N Fujita K Kassai Y Naito M Kondo 2000 A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions Aliment Pharmacol Ther 14 Suppl 1 74 81 10.1046/j.1365-2036.2000.014s1074.x 10807407
31. T Sasaki M Yamaya H Yasuda D Inoue M Yamada H Kubo H Nishimura H Sasaki 2005 The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells Eur J Pharmacol 509 2-3 201 210 10.1016/j.ejphar.2004.12.042 15733557 (Pubitemid 40279079)
32. T Ohara T Arakawa 1999 Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells Dig Dis Sci 44 1710 1715 10.1023/A:1026604203237 10492157 (Pubitemid 29434749)
33. R Martins de Oliveira E Antunes J Pedrazzoli Jr A Gambero 2007 The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore Inflamm Res 56 105 111 10.1007/s00011-006-6127-6 17406807 (Pubitemid 46570795)
34. WB Smith JR Gamble I Clark-Lewis MA Vadas 1991 Interleukin-8 induces neutrophil transendothelial migration Immunology 72 65 72 1997402
35. W Strober 2006 Immunology. Unraveling gut inflammation Science 313 1052 1054 10.1126/science.1131997 16931742 (Pubitemid 44300217)
36. E Verdu F Viani D Armstrong R Fraser HH Siegrist B Pignatelli JP Idstrom C Cederberg AL Blum M Fried 1994 Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds Gut 35 455 460 10.1136/gut.35.4.455 8174980
37. BJ Vesper A Jawdi KW Altman GK Haines III L Tao JA Radosevich 2009 The effect of proton pump inhibitors on the human microbiota Curr Drug Metab 10 84 89 10.2174/138920009787048392 19149516
38. M Nakao P Malfertheiner 1998 Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori Helicobacter 3 21 27 10.1046/j.1523-5378.1998.08024. x 9546114
39. BC Monk AB Mason G Abramochkin JE Haber D Seto-Young DS Perlin 1995 The yeast plasma membrane proton pumping ATPase is a viable antifungal target. I. Effects of the cysteine-modifying reagent omeprazole Biochim Biophys Acta 1239 81 90 10.1016/0005-2736(95)00133-N 7548148
40. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, Bonis P, Hassall E, Straumann A, Rothenberg ME, First International Gastrointestinal Eosinophil Research Symposium (FIGERS) Subcommittees. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342-1363.
41. SJ Spechler RM Genta RF Souza 2007 Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis Am J Gastroenterol 102 1301 1306 10.1111/j.1572-0241.2007.01179.x 17531015 (Pubitemid 46802025)
42. P Ngo GT Furuta DA Antonioli VL Fox 2006 Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia Am J Gastroenterol 101 1666 1670 10.1111/j.1572-0241.2006.00562.x 16863575 (Pubitemid 43980644)
43. SS Aceves GT Furuta SJ Spechler 2008 Integrated approach to treatment of children and adults with eosinophilic esophagitis Gastrointest Endosc Clin N Am 18 195 217 10.1016/j.giec.2007.09.003 18061112 (Pubitemid 350166936)
44. M Bohm JE Richter 2008 Treatment of eosinophilic esophagitis: overview, current limitations, and future direction Am J Gastroenterol 103 2635 2644 10.1111/j.1572-0241.2008.02116.x 18721234
45. P Rafiee ME Theriot VM Nelson J Heidemann Y Kanaa SA Horowitz A Rogaczewski CP Johnson I Ali R Shaker DG Binion 2006 Human esophageal microvascular endothelial cells respond to acidic pH stress by PI3K/AKT and p38 MAPK-regulated induction of Hsp70 and Hsp27 Am J Physiol Cell Physiol 291 C931 C945 10.1152/ajpcell.00474.2005 16790501 (Pubitemid 44771812)
46. SR Barthel DS Annis DF Mosher MW Johansson 2006 Differential engagement of modules 1 and 4 of vascular cell adhesion molecule-1 (CD106) by integrins alpha4beta1 (CD49d/29) and alphaMbeta2 (CD11b/18) of eosinophils J Biol Chem 281 32175 32187 10.1074/jbc.M600943200 16943205 (Pubitemid 46036772)
47. RJ Laheij MC Sturkenboom RJ Hassing J Dieleman BH Stricker JB Jansen 2004 Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs JAMA 292 1955 1960 10.1001/jama.292.16.1955 15507580 (Pubitemid 39411203)
48. SJ Herzig MD Howell LH Ngo ER Marcantonio 2009 Acid-suppressive medication use and the risk for hospital-acquired pneumonia JAMA 301 2120 2128 10.1001/jama.2009.722 19470989
49. JS Bajaj Y Zadvornova DM Heuman M Hafeezullah RG Hoffmann AJ Sanyal K Saeian 2009 Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites Am J Gastroenterol 104 1130 1134 10.1038/ajg.2009.80 19337238